Alkermes (ALKS) EBT Margin (QoQ) (2010 - 2026)
Powered by 
Analysis
Alkermes (ALKS) EBT Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.32 Bn | 623.56 Bn | 17.26 Bn |
| 2 | AbbVie | 440.60 Bn | 434.04 Bn | 12.70 Bn |
| 3 | Merck | 365.39 Bn | 358.25 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 159.22 Bn | 147.52 Bn | 10.94 Bn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.21 Bn | 44.21 Bn | - |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.49 Bn | 18.82 Bn | 683.80 Mn |
| 10 | Alkermes | 7.58 Bn | 6.93 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,538.00 |
| Mar 31, 2026 | -3,146.00 |
| Dec 31, 2025 | -986.00 |
| Sep 30, 2025 | -128.00 |
| Jun 30, 2025 | 1,852.00 |
| Mar 31, 2025 | -3,119.00 |
| Dec 31, 2024 | 1,036.00 |
| Sep 30, 2024 | -9.00 |
| Jun 30, 2024 | 1,585.00 |
| Mar 31, 2024 | -206.00 |
| Dec 31, 2023 | -889.00 |
| Sep 30, 2023 | -2,131.00 |
| Jun 30, 2023 | 4,959.00 |
| Mar 31, 2023 | -4,152.00 |
| Dec 31, 2022 | 6,427.00 |
| Sep 30, 2022 | -1,466.00 |
| Jun 30, 2022 | 412.00 |
| Mar 31, 2022 | -5,538.00 |
| Dec 31, 2021 | 4,824.00 |
| Sep 30, 2021 | -1,088.00 |